Home/Biophytis/Pierre J. Dilda
PJ

Pierre J. Dilda

Chief Scientific Officer

Biophytis

Biophytis Pipeline

DrugIndicationPhase
BIO101 (20-hydroxyecdysone)SarcopeniaPhase 3
MASSIVE Project CandidatesSarcopenia (Next-generation)Discovery
AI Platform CandidatesDry Age-Related Macular Degeneration (AMD)Discovery